Cochrane’s sinking ship and conflicts of interest
We believe Cochrane is a key source of scientific evidence on diagnostic and therapeutic medical issues. The very recent expulsion of Peter Gøtzsche from the Cochrane Board and subsequent retirement of four Board members have great impact on the existence of this organisation. Beside issues mentioned by other authors1-3 we believe this crisis is a good opportunity to fix a big problem raised by Peter Gøtzsche and others about Cochrane’s conflict of interest policy.
Read more...
Download
ISDB Newsletter December 2017.pdf (2.0mb)
Contents
- ISDB 2017 Update of activities and newsletter
- News from ISDB General Assembly and Meeting
- ISDB General Assembly Pamplona 2015
- ISDB Extraordinary General Meeting Leiden 2016
Read more...
Paris, 28 November 2017
Prescrire, along with around 20 civil society organisations, has signed a joint declaration drawing attention to potential problems posed by the provision of confidential scientific advice by the European Medicines Agency to pharmaceutical companies, especially a decline in regulatory standards, a risk of institutional capture, and a total lack of transparency surrounding the activity of European regulatory authorities.
Read more...